3don MSNOpinion
My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...
Increased mixed chimerism, as detected by AlloHeme, could predict post-transplant relapse “with a high degree of accuracy,” said Monzr M. Al Malki, MD.
Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.
Jon Batiste shared a positive update on his wife Suleika Jaouad's health following her September 2024 announcement that she'd ...
Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...
In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
The new findings are the first to describe distributions and perturbations of low-density granulocyte and normal-density ...
Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results